Method for activating NKT cells using PIMs
US7052909B1 · kind B1 · utility
0Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 19, 2000 |
| Grant date | May 30, 2006 |
| Priority date | — |
| Expiry date | Apr 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a pharmaceutical composition comprising at least a PIM-activated NKT cell and the use of at least one PIM and/or a PIM-activated NKT cell for treating a disease for which a granulomatous type of immune response is desired.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.